Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shyam Srivats"'
Autor:
Dmitri Pchejetski, Caroline M. R. Low, Danielle Monteil, Heba Alshaker, Shyam Srivats, Qi Wang
Publikováno v:
Breast Cancer Research and Treatment
Purpose Sphingosine kinase 1 (SK1) is a protooncogenic enzyme expressed in many human tumours and is associated with chemoresistance and poor prognosis. It is a potent therapy target and its inhibition chemosensitises solid tumours. Despite recent ad
Publikováno v:
Breast Cancer Research and Treatment
Purpose Combining molecular therapies with chemotherapy may offer an improved clinical outcome for chemoresistant tumours. Sphingosine-1-phosphate (S1P) receptor antagonist and sphingosine kinase 1 (SK1) inhibitor FTY720 (FTY) has promising anticance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f47dc5fa3e04e07995c6faf227b3dcb
https://ueaeprints.uea.ac.uk/id/eprint/64323/
https://ueaeprints.uea.ac.uk/id/eprint/64323/
Autor:
Shivani Soni, Abhimanyu Paraskar, Sudipta Basu, Shiladitya Sengupta, Rituparna Sinha Roy, Nicola Lupoli, Shyam Srivats, Chitra Amarasiriwardena
The use of cisplatin, a first line chemotherapy for most cancers, is dose-limited due to nephrotoxicity. While this toxicity can be addressed through nanotechnology, previous attempts at engineering cisplatin nanoparticles have been limited by the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be6f30a2578333c0cb2c55f52333af6
https://europepmc.org/articles/PMC3158969/
https://europepmc.org/articles/PMC3158969/